- Home
- NVCT vs SXTC Comparison
NVCT vs SXTC Comparison
Compare NVCT & SXTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NVCT | SXTC |
|---|---|---|
| Founded | 2020 | 2005 |
| Country | | |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 220.0M | 177.7M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | NVCT | SXTC |
|---|---|---|
| Price | $8.94 | $2.50 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $15.33 | N/A |
| AVG Volume (30 Days) | 64.7K | ★ 681.5K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $5.55 | $2.34 |
| 52 Week High | $11.52 | $1,175.99 |
Technical Indicators
Market Signals| Indicator | NVCT | SXTC |
|---|---|---|
| Relative Strength Index (RSI) | 59.78 | 58.34 |
| Support Level | $8.12 | $2.41 |
| Resistance Level | $9.23 | $2.90 |
| Average True Range (ATR) | 0.52 | 0.50 |
| MACD | -0.00 | 0.10 |
| Stochastic Oscillator | 79.07 | 38.18 |
Price Performance
Historical ComparisonAbout NVCT Nuvectis Pharma Inc.
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.
About SXTC China SXT Pharmaceuticals Inc.
China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly, TCMP (Directed-oral TCMP, and After-soaking TCMP) which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates its revenue from the People's Republic of China.